Herpes simplex virus type 1 and Alzheimer’s disease: link and potential impact on treatment

Roberta Mancuso, Mariaconcetta Sicurella, Simone Agostini, Peggy Marconi, Mario Clerici

Research output: Contribution to journalReview article

Abstract

Introduction: Alzheimer’s disease (AD), the most common form of dementia worldwide, is a multifactorial disease with a still unknown etiology. Herpes simplex virus 1 (HSV-1) has long been suspected to be one of the factors involved in the pathogenesis of the disease. Areas covered: We review the literature focusing on viral characteristics of HSV-1, the mechanisms this virus uses to infect neural cells, its interaction with the host immune system and genetic background and summarizes results and research that support the hypothesis of an association between AD and HSV-1. The possible usefulness of virus-directed pharmaceutical approaches as potential treatments for AD will be discussed as well. Expert opinion: We highlight crucial aspects that must be addressed to clarify the possible role of HSV-1 in the pathogenesis of the disease, and to allow the design of new therapeutical approaches for AD.

Original languageEnglish
JournalExpert Review of Anti-Infective Therapy
DOIs
Publication statusPublished - Aug 1 2019

Fingerprint

Human Herpesvirus 1
Virus Diseases
Alzheimer Disease
Viruses
Expert Testimony
Cell Communication
Dementia
Immune System
Pharmaceutical Preparations

Keywords

  • Alzheimer’s disease
  • human herpes simplex virus type-I
  • immunity
  • mild cognitive impairment
  • pharmaceutical treatments

ASJC Scopus subject areas

  • Microbiology
  • Microbiology (medical)
  • Infectious Diseases
  • Virology

Cite this

Herpes simplex virus type 1 and Alzheimer’s disease : link and potential impact on treatment. / Mancuso, Roberta; Sicurella, Mariaconcetta; Agostini, Simone; Marconi, Peggy; Clerici, Mario.

In: Expert Review of Anti-Infective Therapy, 01.08.2019.

Research output: Contribution to journalReview article

@article{a7d13e5d4ac04a81b4e5cda3e16d91c9,
title = "Herpes simplex virus type 1 and Alzheimer’s disease: link and potential impact on treatment",
abstract = "Introduction: Alzheimer’s disease (AD), the most common form of dementia worldwide, is a multifactorial disease with a still unknown etiology. Herpes simplex virus 1 (HSV-1) has long been suspected to be one of the factors involved in the pathogenesis of the disease. Areas covered: We review the literature focusing on viral characteristics of HSV-1, the mechanisms this virus uses to infect neural cells, its interaction with the host immune system and genetic background and summarizes results and research that support the hypothesis of an association between AD and HSV-1. The possible usefulness of virus-directed pharmaceutical approaches as potential treatments for AD will be discussed as well. Expert opinion: We highlight crucial aspects that must be addressed to clarify the possible role of HSV-1 in the pathogenesis of the disease, and to allow the design of new therapeutical approaches for AD.",
keywords = "Alzheimer’s disease, human herpes simplex virus type-I, immunity, mild cognitive impairment, pharmaceutical treatments",
author = "Roberta Mancuso and Mariaconcetta Sicurella and Simone Agostini and Peggy Marconi and Mario Clerici",
year = "2019",
month = "8",
day = "1",
doi = "10.1080/14787210.2019.1656064",
language = "English",
journal = "Expert Review of Anti-Infective Therapy",
issn = "1478-7210",
publisher = "Taylor and Francis Ltd.",

}

TY - JOUR

T1 - Herpes simplex virus type 1 and Alzheimer’s disease

T2 - link and potential impact on treatment

AU - Mancuso, Roberta

AU - Sicurella, Mariaconcetta

AU - Agostini, Simone

AU - Marconi, Peggy

AU - Clerici, Mario

PY - 2019/8/1

Y1 - 2019/8/1

N2 - Introduction: Alzheimer’s disease (AD), the most common form of dementia worldwide, is a multifactorial disease with a still unknown etiology. Herpes simplex virus 1 (HSV-1) has long been suspected to be one of the factors involved in the pathogenesis of the disease. Areas covered: We review the literature focusing on viral characteristics of HSV-1, the mechanisms this virus uses to infect neural cells, its interaction with the host immune system and genetic background and summarizes results and research that support the hypothesis of an association between AD and HSV-1. The possible usefulness of virus-directed pharmaceutical approaches as potential treatments for AD will be discussed as well. Expert opinion: We highlight crucial aspects that must be addressed to clarify the possible role of HSV-1 in the pathogenesis of the disease, and to allow the design of new therapeutical approaches for AD.

AB - Introduction: Alzheimer’s disease (AD), the most common form of dementia worldwide, is a multifactorial disease with a still unknown etiology. Herpes simplex virus 1 (HSV-1) has long been suspected to be one of the factors involved in the pathogenesis of the disease. Areas covered: We review the literature focusing on viral characteristics of HSV-1, the mechanisms this virus uses to infect neural cells, its interaction with the host immune system and genetic background and summarizes results and research that support the hypothesis of an association between AD and HSV-1. The possible usefulness of virus-directed pharmaceutical approaches as potential treatments for AD will be discussed as well. Expert opinion: We highlight crucial aspects that must be addressed to clarify the possible role of HSV-1 in the pathogenesis of the disease, and to allow the design of new therapeutical approaches for AD.

KW - Alzheimer’s disease

KW - human herpes simplex virus type-I

KW - immunity

KW - mild cognitive impairment

KW - pharmaceutical treatments

UR - http://www.scopus.com/inward/record.url?scp=85070946215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070946215&partnerID=8YFLogxK

U2 - 10.1080/14787210.2019.1656064

DO - 10.1080/14787210.2019.1656064

M3 - Review article

AN - SCOPUS:85070946215

JO - Expert Review of Anti-Infective Therapy

JF - Expert Review of Anti-Infective Therapy

SN - 1478-7210

ER -